全腔镜下肺叶切除术与开胸肺叶切除术治疗非小细胞肺癌比较的临床分析

[摘要] 目的 比^全腔镜下肺叶切除术与开胸肺叶切除术治疗非小细胞肺癌的临床治疗效果。方法 整群选取该院2011年5月―2014年5月收治的116例非小细胞肺癌患者，按照就诊时间的单双号，将其分为对照组和观察组，每组58例，对对照组行开胸肺叶切除术治疗，对观察组患者行全腔镜下肺叶切除术治疗，对比两组患者的术后临床指标以及1年后的生存率与复发率。 结果 对照组的术后镇痛时间为（5.4±1.3）d、术后住院时间时间为（13.5±5.6）d、术后胸腔引流量为（403.4±87.4）mL、术中出血量为（160.3±39.2）mL、切口长度为（21.6±5.5）cm；观察组的术后镇痛时间为（3.5±1.2）d、术后住院时间时间为（7.0±2.1）d、术后胸腔引流量为（231.2±44.3）mL、术中出血量为（96.3±31.3）mL、切口长度为（4.7±2.4）cm。观察组患者的术后临床指标优于对照组，差异具有统计学意义（P0.05）。对照组达到了6.9%的1年复发率、100.0%的1年生存率，观察组达到了8.6%的1年复发率、100.0%的1年生存率，观察组患者1年后的生存率和复发率与对照组的差异无统计学意义（P>0.05）。结论 全腔镜下肺叶切除术疗效好，且有利于促进患者恢复、减轻术后疼痛，减少手术创伤，是一种值得临床推广的非小细胞肺癌治疗方式。

[关键词] 非小细胞肺癌；开胸肺叶切除术；全腔镜下肺叶切除术

[中图分类号] R73 [文献标识码] A [文章编号] 1674-0742（2016）11（c）-0074-03

[Abstract] Objective Clinical comparison of therapeutic effects of endoscopic lobectomy and thoracotomy lobectomy for non-small cell lung cancer. Methods Group select our hospital May 2011 to May 2014 from 116 cases of non small cell lung cancer patients， According to the single visit time，divided for the observation group and the control group， in the control group underwent thoracotomy with lobectomy in the treatment， the observation group patients for thoracoscopic lobectomy in the treatment of patients with， compared two groups of patients with postoperative temporary bed index and after 1 year survival rate and recurrence rate. Results Control group the postoperative pain time for （5.4 ± 1.3）d， postoperative hospitalization time for （13.5±5.6）d， postoperative chest drainage for （40.34± 87.4）mL， intraoperative bleeding was （160.3±39.2）mL， the length of incision for （21.6±5.5）cm； in the observation group， the postoperative pain time for （3.5±1.2）d， postoperative hospitalization time for（7.0±2.1）d， postoperative chest drainage for（23.12±44.3）mL， intraoperative bleeding was （96.3±31.3）mL， the length of incision for（4.7± 2.4）cm. Compared with the control group， the clinical indexes of the observation group were better than the control group， the difference was statistically significant （P < 0.05）， but there was no significant difference between the operation time and the number of lymph nodes （P > 0.05）. Control group reached 6.9% 1-year recurrence rate and 100.0% of the 1 year survival rate， the observation group reached 8.6% 1-year recurrence rate， 100.0% of the 1 year survival rate observed groups of patients after 1 year survival rate and recurrence rate and control group differences had no statistical significance （P > 0.05）. Conclusion Thoracoscopic lobectomy are conducive to promoting the recovery of patients， reduce postoperative pain， reduce the surgical trauma is a worthy of clinical promotion of non small cell lung cancer treatment.